New Training Programs in Health Economics and Outcomes Research Announced

Published Mar 19, 2018
ISPOR’s Essential HEOR Education Program Schedule Now Open for Registration Lawrenceville, NJ, USA—March 19, 2018—ISPOR, the professional society for health economics and outcomes research, announced the opening of training programs scheduled for the first half of 2018. ISPOR’s Essential HEOR Training Program provides professional training and education in the field of health economics and outcomes research (HEOR) that covers a wide variety of course topics. Training programs currently available for registration include: Patient-Reported Outcomes April 10-11, 2018 | Chapel Hill, Durham, NC, USA Patient-reported outcomes (PROs) are increasingly in demand by patients, providers, payers, and regulators seeking to assess if new healthcare interventions make a real difference in people’s lives. The Patient-Reported Outcomes training program provides students with the knowledge necessary to incorporate PROs into clinical research. Faculty for the program includes Bryce B. Reeve, PhD and Kevin Weinfurt, PhD. HEOR Short Course Program (at ISPOR 2018) May 19-20, 2018 | Baltimore, MD, USA The ISPOR HEOR Short Course Program is offered at ISPOR conferences around the world and the program at ISPOR 2018 is now open for registration. This program offers 37 half- and full-day courses in HEOR that include 11 new course topics and options for every professional level. Faculty includes experts in HEOR from around the globe. Health Technology Assessment The ISPOR Health Technology Assessment Training Program is designed for health technology assessment (HTA) “users and doers” in government in addition to public and private payers, industry, health plans, academia, and patient group representatives interested in learning how to conduct various aspects of HTA with an emphasis on clinical and economic evaluation. This course will be offered:
  • June 19-21, 2018 | Princeton, NJ, USA: A 3-day session of the ISPOR Health Technology Assessment Training Program will be held in Princeton, NJ, USA. This is the first time that ISPOR’s HTA training will be offered in the United States. This program will focus on how payers evaluate biopharmaceutical products and other technologies in the United States. Faculty includes Finn Børlum Kristensen, MD, PhD; Lou Garrison, PhD; Beth Devine, PhD, PharmD, MBA; and Zoltán Kaló, MSc, MD, PhD.
  • 23-26 July 2018 | Lima, Peru A 3.5-day session of the ISPOR Health Technology Assessment Training Program will be held in Lima, Peru. Program faculty includes Finn Børlum Kristensen, MD, PhD, Manuel Espinoza, MD, MSc, PhD, and Aurelio Mejía, MSc.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Announces New Strategic Plan 2030

Jul 29, 2024

ISPOR announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×